Metropolitan Life Insurance Company (MetLife)’s Amgen AMGN Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-21,578	Closed	-$6.14M	–	118
2024 Q1	$6.14M	Sell	21,578 -206	-0.9%	-$60.3K	0.27%	63
2023 Q4	$6.27M	Sell	21,784 -348	-2%	-$94.8K	0.29%	56
2023 Q3	$5.95M	Sell	22,132 -1,153	-5%	-$288K	0.31%	54
2023 Q2	$5.17M	Sell	23,285 -599	-3%	-$139K	0.25%	75
2023 Q1	$5.77M	Sell	23,884 -5,726	-19%	-$1.41M	0.3%	63
2022 Q4	$7.78M	Sell	29,610 -1,775	-6%	-$476K	0.35%	56
2022 Q3	$7.07M	Sell	31,385 -331	-1%	-$80.2K	0.34%	56
2022 Q2	$7.72M	Sell	31,716 -2,559	-7%	-$627K	0.34%	58
2022 Q1	$8.29M	Sell	34,275 -51,539	-60%	-$11.8M	0.3%	63
2021 Q4	$19.3M	Sell	85,814 -2,442	-3%	-$515K	0.26%	66
2021 Q3	$18.8M	Sell	88,256 -4,006	-4%	-$922K	0.27%	65
2021 Q2	$22.5M	Sell	92,262 -9,088	-9%	-$2.24M	0.32%	53
2021 Q1	$25.2M	Sell	101,350 -6,361	-6%	-$1.52M	0.38%	47
2020 Q4	$24.8M	Sell	107,711 -5,093	-5%	-$1.17M	0.37%	46
2020 Q3	$28.7M	Sell	112,804 -4,854	-4%	-$1.2M	0.49%	33
2020 Q2	$27.8M	Buy	117,658 +3,925	+3%	+$896K	0.49%	31
2020 Q1	$23.1M	Sell	113,733 -2,222	-2%	-$485K	0.47%	37
2019 Q4	$28M	Sell	115,955 -1,150	-1%	-$253K	0.45%	33
2019 Q3	$22.7M	Sell	117,105 -3,777	-3%	-$725K	0.38%	48
2019 Q2	$22.3M	Buy	120,882 +4,291	+4%	+$768K	0.38%	46
2019 Q1	$22.1M	Sell	116,591 -6,325	-5%	-$1.21M	0.4%	41
2018 Q4	$23.9M	Sell	122,916 -2,654	-2%	-$518K	0.48%	33
2018 Q3	$26M	Sell	125,570 -6,362	-5%	-$1.25M	0.44%	37
2018 Q2	$24.4M	Buy	131,932 +17,806	+16%	+$3.15M	0.39%	44
2018 Q1	$19.5M	Sell	114,126 -7,149	-6%	-$1.31M	0.27%	56
2017 Q4	$21.1M	Sell	121,275 -233,810	-66%	-$41.4M	0.28%	51
2017 Q3	$66.2M	Sell	355,085 -8,956	-2%	-$1.59M	0.41%	42
2017 Q2	$62.7M	Sell	364,041 -31,063	-8%	-$5.05M	0.43%	43
2017 Q1	$64.8M	Sell	395,104 -9,070	-2%	-$1.51M	0.45%	40
2016 Q4	$59.1M	Sell	404,174 -12,721	-3%	-$1.91M	0.42%	38
2016 Q3	$69.5M	Sell	416,895 -6,555	-2%	-$1.11M	0.51%	36
2016 Q2	$64.4M	Sell	423,450 -4,976	-1%	-$774K	0.48%	39
2016 Q1	$64.2M	Sell	428,426 -7,682	-2%	-$1.14M	0.49%	40
2015 Q4	$70.8M	Sell	436,108 -5,229	-1%	-$822K	0.54%	33
2015 Q3	$61M	Sell	441,337 -8,643	-2%	-$1.36M	0.44%	42
2015 Q2	$69.1M	Buy	449,980 +5,760	+1%	+$923K	0.49%	36
2015 Q1	$71M	Sell	444,220 -6,525	-1%	-$1.03M	0.52%	34
2014 Q4	$71.8M	Sell	450,745 -1,121	-0.2%	-$175K	0.5%	36
2014 Q3	$63.5M	Sell	451,866 -5,882	-1%	-$768K	0.46%	37
2014 Q2	$54.2M	Sell	457,748 -21,182	-4%	-$2.45M	0.38%	45
2014 Q1	$59.1M	Sell	478,930 -6,886	-1%	-$835K	0.41%	42
2013 Q4	$55.5M	Sell	485,816 -8,958	-2%	-$1.02M	0.39%	45
2013 Q3	$55.4M	Sell	494,774 -1,957	-0.4%	-$212K	0.42%	40
2013 Q2	$49M	Buy	+496,731	New	+$51.5M	0.39%	40

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s AMGN Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Amgen (AMGN) in Q2 2024, closing a stake of 21,578 shares — an estimated $6.14M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AMGN in Q2 2013 and held it in 44 quarters. The position peaked at $71.8M in Q4 2014. 2,785 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 21,578 Amgen shares in Q2 2024, an estimated $6.14M.
Metropolitan Life Insurance Company (MetLife) first reported a position in Amgen in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Amgen position peaked at $71.8M in Q4 2014.
2,785 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.